{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T16:37:39Z","timestamp":1789403859659,"version":"build-2803163510"},"reference-count":32,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.6777","type":"journal-article","created":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T23:49:06Z","timestamp":1591314546000},"page":"e206777","source":"Crossref","is-referenced-by-count":32,"title":["Dose Timing of <scp>D<\/scp>-Cycloserine to Augment Exposure Therapy for Social Anxiety Disorder"],"prefix":"10.1001","volume":"3","author":[{"given":"Jasper A. J.","family":"Smits","sequence":"first","affiliation":[{"name":"Institute for Mental Health Research, Department of Psychology, The University of Texas at Austin, Austin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark H.","family":"Pollack","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Rush University Medical Center, Chicago, Illinois"},{"name":"Now with Myriad Genetics, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rosenfield","sequence":"additional","affiliation":[{"name":"Department of Psychology, Southern Methodist University, Dallas, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Otto","sequence":"additional","affiliation":[{"name":"Department of Psychological and Brain Sciences, Boston University, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"Dowd","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Rush University Medical Center, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Carpenter","sequence":"additional","affiliation":[{"name":"Department of Psychological and Brain Sciences, Boston University, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina D.","family":"Dutcher","sequence":"additional","affiliation":[{"name":"Institute for Mental Health Research, Department of Psychology, The University of Texas at Austin, Austin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Lewis","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Rush University Medical Center, Chicago, Illinois"},{"name":"Department of Psychology, Louisiana State University, Baton Rouge"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara M.","family":"Witcraft","sequence":"additional","affiliation":[{"name":"Institute for Mental Health Research, Department of Psychology, The University of Texas at Austin, Austin"},{"name":"Department of Psychology, University of Mississippi, Oxford"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Papini","sequence":"additional","affiliation":[{"name":"Institute for Mental Health Research, Department of Psychology, The University of Texas at Austin, Austin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Curtiss","sequence":"additional","affiliation":[{"name":"Department of Psychological and Brain Sciences, Boston University, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh","family":"Andrews","sequence":"additional","affiliation":[{"name":"Department of Psychology, Southern Methodist University, Dallas, Texas"},{"name":"Department of Psychological and Brain Sciences, University of Delaware, Newark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley","family":"Kind","sequence":"additional","affiliation":[{"name":"Department of Psychological and Brain Sciences, Boston University, Boston, Massachusetts"},{"name":"Department of Psychology, Suffolk University, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Conroy","sequence":"additional","affiliation":[{"name":"Department of Psychological and Brain Sciences, Boston University, Boston, Massachusetts"},{"name":"Department of Psychology, Florida International University, Coral Gables"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan G.","family":"Hofmann","sequence":"additional","affiliation":[{"name":"Department of Psychological and Brain Sciences, Boston University, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2020,6,4]]},"reference":[{"issue":"11","key":"zoi200305r1","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1001\/archpsyc.61.11.1136","article-title":"Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.","volume":"61","author":"Ressler","year":"2004","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"zoi200305r2","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.biopsych.2006.03.084","article-title":"Effects of D-cycloserine on extinction: translation from preclinical to clinical work.","volume":"60","author":"Davis","year":"2006","journal-title":"Biol Psychiatry"},{"issue":"6","key":"zoi200305r3","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/da.2018.35.issue-6","article-title":"Cognitive behavioral therapy for anxiety and related disorders: a meta-analysis of randomized placebo-controlled trials.","volume":"35","author":"Carpenter","year":"2018","journal-title":"Depress Anxiety"},{"issue":"4","key":"zoi200305r4","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.biopsych.2006.06.022","article-title":"The promise of extinction research for the prevention and treatment of anxiety disorders.","volume":"60","author":"Anderson","year":"2006","journal-title":"Biol Psychiatry"},{"issue":"5","key":"zoi200305r5","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1001\/jamapsychiatry.2016.3955","article-title":"D-cycloserine augmentation of exposure-based cognitive behavior therapy for anxiety, obsessive-compulsive, and posttraumatic stress disorders: a systematic review and meta-analysis of individual participant data.","volume":"74","author":"Mataix-Cols","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"zoi200305r6","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.biopsych.2015.09.007","article-title":"Enhancement of psychosocial treatment with D-cycloserine: models, moderators, and future directions.","volume":"80","author":"Otto","year":"2016","journal-title":"Biol Psychiatry"},{"key":"zoi200305r7","doi-asserted-by":"crossref","DOI":"10.1016\/j.janxdis.2019.102149","article-title":"Changes in dosing and dose timing of D-cycloserine explain its apparent declining efficacy for augmenting exposure therapy for anxiety-related disorders: an individual participant-data meta-analysis.","volume":"68","author":"Rosenfield","year":"2019","journal-title":"J Anxiety Disord"},{"issue":"11","key":"zoi200305r8","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.biopsych.2012.12.009","article-title":"D-cycloserine enhancement of fear extinction is specific to successful exposure sessions: evidence from the treatment of height phobia.","volume":"73","author":"Smits","year":"2013","journal-title":"Biol Psychiatry"},{"issue":"10","key":"zoi200305r9","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.jpsychires.2013.06.020","article-title":"D-cycloserine enhancement of exposure therapy for social anxiety disorder depends on the success of exposure sessions.","volume":"47","author":"Smits","year":"2013","journal-title":"J Psychiatr Res"},{"issue":"11","key":"zoi200305r10","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.biopsych.2013.10.008","article-title":"Yohimbine enhancement of exposure therapy for social anxiety disorder: a randomized controlled trial.","volume":"75","author":"Smits","year":"2014","journal-title":"Biol Psychiatry"},{"issue":"10","key":"zoi200305r11","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1176\/appi.ajp.2014.13101407","article-title":"Effects of post-session administration of methylene blue on fear extinction and contextual memory in adults with claustrophobia.","volume":"171","author":"Telch","year":"2014","journal-title":"Am J Psychiatry"},{"key":"zoi200305r12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.janxdis.2015.06.005","article-title":"Extinction learning as a moderator of D-cycloserine efficacy for enhancing exposure therapy in posttraumatic stress disorder.","volume":"34","author":"de Kleine","year":"2015","journal-title":"J Anxiety Disord"},{"issue":"5","key":"zoi200305r13","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1097\/JCP.0000000000000757","article-title":"No effects of D-cycloserine enhancement in exposure with response prevention therapy in panic disorder with agoraphobia: a double-blind, randomized controlled trial.","volume":"37","author":"Hofmeijer-Sevink","year":"2017","journal-title":"J Clin Psychopharmacol"},{"key":"zoi200305r14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jpsychires.2018.08.016","article-title":"Learn to forget: does post-exposure administration of D-cycloserine enhance fear extinction in agoraphobia?","volume":"105","author":"Pyrkosch","year":"2018","journal-title":"J Psychiatr Res"},{"issue":"6","key":"zoi200305r15","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1176\/appi.ajp.2014.13121625","article-title":"A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans.","volume":"171","author":"Rothbaum","year":"2014","journal-title":"Am J Psychiatry"},{"issue":"6","key":"zoi200305r16","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.biopsych.2007.11.011","article-title":"A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder.","volume":"63","author":"Guastella","year":"2008","journal-title":"Biol Psychiatry"},{"key":"zoi200305r17","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.cct.2015.06.015","article-title":"Dose timing of D-cycloserine to augment cognitive behavioral therapy for social anxiety: study design and rationale.","volume":"43","author":"Hofmann","year":"2015","journal-title":"Contemp Clin Trials"},{"key":"zoi200305r18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1745-6215-11-32","article-title":"CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials.","volume":"11","author":"Schulz","year":"2010","journal-title":"Trials"},{"key":"zoi200305r19","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1159\/issn.0077-0094","article-title":"Social phobia.","volume":"22","author":"Liebowitz","year":"1987","journal-title":"Mod Probl Pharmacopsychiatry"},{"issue":"4","key":"zoi200305r20","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1001\/archpsyc.49.4.290","article-title":"Phenelzine vs atenolol in social phobia: a placebo-controlled comparison.","volume":"49","author":"Liebowitz","year":"1992","journal-title":"Arch Gen Psychiatry"},{"issue":"10","key":"zoi200305r21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223729","article-title":"Effect of D-cycloserine on fear extinction training in adults with social anxiety disorder.","volume":"14","author":"Hofmann","year":"2019","journal-title":"PLoS One"},{"issue":"3","key":"zoi200305r22","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1001\/archpsyc.63.3.298","article-title":"Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.","volume":"63","author":"Hofmann","year":"2006","journal-title":"Arch Gen Psychiatry"},{"issue":"7","key":"zoi200305r23","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1176\/appi.ajp.2013.12070974","article-title":"D-cycloserine as an augmentation strategy with cognitive-behavioral therapy for social anxiety disorder.","volume":"170","author":"Hofmann","year":"2013","journal-title":"Am J Psychiatry"},{"issue":"2","key":"zoi200305r28","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.cpr.2007.04.009","article-title":"Cognitive processes during fear acquisition and extinction in animals and humans: implications for exposure therapy of anxiety disorders.","volume":"28","author":"Hofmann","year":"2008","journal-title":"Clin Psychol Rev"},{"issue":"6","key":"zoi200305r29","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1176\/appi.ajp.2009.09040458","article-title":"Last observation carried forward versus mixed models in the analysis of psychiatric clinical trials.","volume":"166","author":"Hamer","year":"2009","journal-title":"Am J Psychiatry"},{"issue":"1","key":"zoi200305r31","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1037\/a0030048","article-title":"A regression framework for effect size assessments in longitudinal modeling of group differences.","volume":"17","author":"Feingold","year":"2013","journal-title":"Rev Gen Psychol"},{"issue":"4","key":"zoi200305r32","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv102","article-title":"D-cycloserine in neuropsychiatric diseases: a systematic review.","volume":"19","author":"Schade","year":"2016","journal-title":"Int J Neuropsychopharmacol"},{"key":"zoi200305r24","volume-title":"Structured Clinical Interview for DSM-5\u00ae Disorders\u2014Clinical Trials Version (SCID-5-CT)","author":"First","year":"2015"},{"key":"zoi200305r25","volume-title":"Anxiety and Related Disorders Interview Schedule for DSM-5 (ADIS-5)\u00ae\u2014Adult Version: Client Interview Schedule 5-Copy Set","author":"Brown","year":"2014"},{"key":"zoi200305r26","volume-title":"Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"key":"zoi200305r27","volume-title":"Psychotherapy by Reciprocal Inhibition","author":"Wolpe","year":"1958"},{"key":"zoi200305r30","doi-asserted-by":"crossref","DOI":"10.4324\/9781315650982","volume-title":"Multilevel Analysis: Techniques and Applications","author":"Hox","year":"2017","edition":"3rd ed"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2766781\/smits_2020_oi_200305.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T23:49:10Z","timestamp":1591314550000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2766781"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2020,6,4]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.6777","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,4]]}}}